The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.

@article{Sasso2012TheCA,
  title={The controlled attenuation parameter (CAP): a novel tool for the non-invasive evaluation of steatosis using Fibroscan.},
  author={Magali Sasso and V{\'e}ronique Miette and Laurent Sandrin and Michel Beaugrand},
  journal={Clinics and research in hepatology and gastroenterology},
  year={2012},
  volume={36 1},
  pages={13-20}
}
Steatosis is a reversible and benign condition. However, in a few cases, steatosis is associated with inflammation and hepatocyte changes, and is then defined as steato-hepatitis. Steatosis can also be a co-factor in many chronic liver diseases that can lead to fibrosis and cirrhosis. Although an important parameter, until now, evaluation of steatosis by non-invasive methods has remained challenging. In this paper, we report on the use of a novel non-invasive methodology called a controlled… CONTINUE READING

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Usefulness of controlled attenuation parameter for detecting increased arterial stiffness in general population.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver • 2018

References

Publications referenced by this paper.
Showing 1-10 of 66 references

Novel Controlled Attenuation Parameter ( CAP ) for non - invasive assessment of steatosis using Fibroscan ® : performance in chronic hepatitis C

J Vergniol, J Foucher, +5 authors C Fournier
J Viral Hepatitis • 2011

Feasibility of liver transient elastography with FibroScan using a new probe for obese patients.

Liver international : official journal of the International Association for the Study of the Liver • 2010

Similar Papers

Loading similar papers…